These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23129443)
1. Amycolamicin: a novel broad-spectrum antibiotic inhibiting bacterial topoisomerase. Sawa R; Takahashi Y; Hashizume H; Sasaki K; Ishizaki Y; Umekita M; Hatano M; Abe H; Watanabe T; Kinoshita N; Homma Y; Hayashi C; Inoue K; Ohba S; Masuda T; Arakawa M; Kobayashi Y; Hamada M; Igarashi M; Adachi H; Nishimura Y; Akamatsu Y Chemistry; 2012 Dec; 18(49):15772-81. PubMed ID: 23129443 [TBL] [Abstract][Full Text] [Related]
2. Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity. Trzoss M; Bensen DC; Li X; Chen Z; Lam T; Zhang J; Creighton CJ; Cunningham ML; Kwan B; Stidham M; Nelson K; Brown-Driver V; Castellano A; Shaw KJ; Lightstone FC; Wong SE; Nguyen TB; Finn J; Tari LW Bioorg Med Chem Lett; 2013 Mar; 23(5):1537-43. PubMed ID: 23294697 [TBL] [Abstract][Full Text] [Related]
3. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678 [TBL] [Abstract][Full Text] [Related]
4. Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity. Tari LW; Trzoss M; Bensen DC; Li X; Chen Z; Lam T; Zhang J; Creighton CJ; Cunningham ML; Kwan B; Stidham M; Shaw KJ; Lightstone FC; Wong SE; Nguyen TB; Nix J; Finn J Bioorg Med Chem Lett; 2013 Mar; 23(5):1529-36. PubMed ID: 23352267 [TBL] [Abstract][Full Text] [Related]
5. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606 [TBL] [Abstract][Full Text] [Related]
6. Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Phillips JW; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; Lee S; Skwish S; de la Cruz M; Martín J; Vicente F; Genilloud O; Lu J; Painter RE; Young K; Overbye K; Donald RG; Singh SB Chem Biol; 2011 Aug; 18(8):955-65. PubMed ID: 21867911 [TBL] [Abstract][Full Text] [Related]
7. Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode. Lu J; Patel S; Sharma N; Soisson SM; Kishii R; Takei M; Fukuda Y; Lumb KJ; Singh SB ACS Chem Biol; 2014 Sep; 9(9):2023-31. PubMed ID: 24992706 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV. Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212 [TBL] [Abstract][Full Text] [Related]
9. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms. Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062 [TBL] [Abstract][Full Text] [Related]
10. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents. Tari LW; Li X; Trzoss M; Bensen DC; Chen Z; Lam T; Zhang J; Lee SJ; Hough G; Phillipson D; Akers-Rodriguez S; Cunningham ML; Kwan BP; Nelson KJ; Castellano A; Locke JB; Brown-Driver V; Murphy TM; Ong VS; Pillar CM; Shinabarger DL; Nix J; Lightstone FC; Wong SE; Nguyen TB; Shaw KJ; Finn J PLoS One; 2013; 8(12):e84409. PubMed ID: 24386374 [TBL] [Abstract][Full Text] [Related]
11. Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities. Singh SB; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; de la Cruz M; Martín J; Vicente F; Genilloud O; Donald RG; Phillips JW Bioorg Med Chem Lett; 2012 Dec; 22(23):7127-30. PubMed ID: 23084277 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity. Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485 [TBL] [Abstract][Full Text] [Related]
13. New inhibitors of bacterial topoisomerase GyrA/ParC subunits. Black MT; Coleman K Curr Opin Investig Drugs; 2009 Aug; 10(8):804-10. PubMed ID: 19649925 [TBL] [Abstract][Full Text] [Related]
14. Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy. Sherer BA; Hull K; Green O; Basarab G; Hauck S; Hill P; Loch JT; Mullen G; Bist S; Bryant J; Boriack-Sjodin A; Read J; DeGrace N; Uria-Nickelsen M; Illingworth RN; Eakin AE Bioorg Med Chem Lett; 2011 Dec; 21(24):7416-20. PubMed ID: 22041057 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796 [TBL] [Abstract][Full Text] [Related]
16. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents. Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790 [TBL] [Abstract][Full Text] [Related]
17. DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae. Park HS; Jung SJ; Kwak JH; Choi DR; Choi EC Int J Antimicrob Agents; 2010 Jul; 36(1):97-8. PubMed ID: 20403681 [No Abstract] [Full Text] [Related]
18. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors. Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042 [TBL] [Abstract][Full Text] [Related]
19. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens. Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686 [TBL] [Abstract][Full Text] [Related]
20. Structure aided design of chimeric antibiotics. Karoli T; Mamidyala SK; Zuegg J; Fry SR; Tee EH; Bradford TA; Madala PK; Huang JX; Ramu S; Butler MS; Cooper MA Bioorg Med Chem Lett; 2012 Apr; 22(7):2428-33. PubMed ID: 22406152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]